Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The effects of the tricyclic antidepressant amitriptyline on the rat hypothalamic-pituitary-adrenocortical (HPA) system were studied. The time-course experiments showed that amitriptyline, given via the drinking water (4.5 mg/kg.day), produces significant decreases (P < 0.05) in adrenal weight after 5 (-20%) and 7 weeks (-21%) of treatment. Hippocampal mineralocorticoid receptor (MR) levels were down-regulated at days 3 (-27%) and 7 (-20%), and transiently up-regulated at 2 (+40%), 5 (+74%), and 7 (+18%) weeks of treatment. Hippocampal glucocorticoid receptor (GR) levels were slightly down-regulated at days 3 (-8%) and 7 (-17%), transiently up-regulated by 26% at 5 weeks, and indistinguishable from controls after 7 weeks of treatment. MR levels were unchanged in the hypothalamus and neocortex, whereas hypothalamic GR concentrations were elevated and neocortical receptor levels were not altered. Dose-response experiments showed significant decreases in adrenal weight when rats were treated with 4.5 (-14%), 8.8 (-16%) and 14.5 (-13%) mg/kg.day antidepressant, but this applied only for the 4.5- (-14%) and 8.8- (-12%) mg/kg.day doses when the ratio of adrenal weight to body weight was considered. The dose-response relationship regarding hippocampal GR content displayed an inverted U-shaped curve, whereas this was less marked for MR levels. A dose of 4.5 mg/kg.day appeared to be optimal for the rise in MR as well as GR. Concerning the neuroendocrine implications of chronic antidepressant treatment, amitriptyline (5 weeks, 4.5 mg/kg.day) produced significant decreases in basal (ACTH, -47%; corticosterone, -31%) as well as stress (30 min novel environment)-induced plasma ACTH (-38%) and corticosterone (-57%) levels. Previous experiments have forwarded a role of limbic MR in the tonic control of basal HPA activity. Based on the present data, we hypothesize that during amitriptyline treatment a rise in limbic MR may be the initial phenomenon in a successively adjusting HPA system, as evidenced by the decreasing plasma hormone concentrations, declining adrenal size, and up-regulation of GR in particular brain regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Adrenal steroid receptors and actions in the nervous system
McEwen, B. S., De Kloet, E. R., & Rostene, W. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.1121 · Cited by 1,232
Brain corticosteroid receptor balance and homeostatic control
de Kloet, E. R. (1991) · Frontiers in Neuroendocrinology · Cited by 842
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Regulation of ACTH Secretion: Variations on a Theme of B
DALLMAN, M. F., AKANA, S. F., CASCIO, C. S., DARLINGTON, D. N., JACOBSON, L., & LEVIN, N. (1987) · Proceedings of the 1986 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571143-2.50010-1 · Cited by 655
De Kloet, E. R., & Reul, J. M. H. M. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90040-0 · Cited by 598
Self-citationVETULANI, J., & SULSER, F. (1975) · Nature · doi:10.1038/257495a0 · Cited by 594
FUXE, K., WIKSTRÖM, A.-C., OKRET, S., AGNATI, L. F., HÄRFSTRAND, A., YU, Z.-Y., GRANHOLM, L., ZOLI, M., VALE, W., & GUSTAFSSON, J.-Å. (1985) · Endocrinology · doi:10.1210/endo-117-5-1803 · Cited by 507
Cited by
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
“Although this review is not focused on the MR, it is worth mentioning that MR upregulation by chronic treatment with antidepressants and electroconvulsive shock also has been described (Przegalinski et al 1993; Reul et al 1993, 1994; Seckl and Fink 1992; Yau et al 1995; Young et al 1990).”
BackgroundThe stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“In addition, antidepressant drugs attenuate the synthesis of CRH by stimulation and/or upregulation of corticosteroid receptor expression (Reus et al., 1997; Fischer et al., 1990; Brady et al., 1991, 1992; Delbende et al., 1991; Reul et al., 1993; Nemeroff, 1996; Yau et al., 1995, 2002; Pariante and Miller, 2001; Pari…”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654
Self-citationCorticosteroids in relation to fear, anxiety and psychopathology
Korte, S. M. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00002-1 · Cited by 607
Chronic pain, chronic stress and depression: Coincidence or consequence?
Blackburn‐Munro, G., & Blackburn‐Munro, R. E. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.0007-1331.2001.00727.x · Cited by 493
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473
“…treatment, hippocampal MR capacity increases in rats (hatched bars), while (B) stress-induced plasma corticosterone concentrations decrease (Reul et al. 1993); (C) the synthetic GR agonist dexamethasone (DEX) induces apoptosis, an effect that is counteracted by the MR agonist aldosterone…”
BackgroundSelf-citationImplication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression
Barden, N. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0421 · Cited by 416
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 411
Interleukin-1 (IL-1): A central regulator of stress responses
Goshen, I., & Yirmiya, R. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.10.001 · Cited by 399
Barden, N., Reul, J. M. H. M., & Holsboer, F. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93942-q · Cited by 391
Self-citationChronic stress: Implications for neuronal morphology, function and neurogenesis
Joëls, M., Karst, H., Krugers, H. J., & Lucassen, P. J. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.04.001 · Cited by 381
Forebrain Pathways Mediating Stress-Induced Hormone Secretion
Van de Kar, L. D., & Blair, M. L. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0172 · Cited by 380
Boyle, M. P., Brewer, J. A., Funatsu, M., Wozniak, D. F., Tsien, J. Z., Izumi, Y., & Muglia, L. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406458102 · Cited by 378
van Praag, H. M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.031 · Cited by 377
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Self-citationEffects of long-term voluntary exercise on the mouse hypothalamic–pituitary–adrenocortical axis
Droste, S. K., Gesing, A., Ulbricht, S., Müller, M. B., Linthorst, A. C. E., & Reul, J. M. H. M. (2003) · Endocrinology · doi:10.1210/en.2003-0097 · Cited by 324
“novel environment) but not to more severe stressors such as forced swimming (25, 96) (Gesing, A.”
BackgroundSelf-citationPolymorphisms of the Glucocorticoid Receptor Gene and Major Depression
van Rossum, E. F. C., Binder, E. B., Majer, M., Koper, J. W., Ising, M., Modell, S., Salyakina, D., Lamberts, S. W. J., & Holsboer, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.007 · Cited by 324
Xu, Y., Ku, B., Tie, L., Yao, H., Jiang, W., Ma, X., & Li, X. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.009 · Cited by 298
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.93 · Cited by 275
DEJONG, I., PRELLE, I., VANDEBURGWAL, J., LAMBOOIJ, E., KORTE, S., BLOKHUIS, H., & KOOLHAAS, J. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00212-7 · Cited by 268
Bornstein, S. R., Schuppenies, A., Wong, M.-L., & Licinio, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001873 · Cited by 266
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265
“It has been suggested that normalization of GR function is the common antidepressant mechanism that allows improved negative feedback to the HPA and restoration of normal neuroendocrine function (75).”
BackgroundMakino, S., Hashimoto, K., & Gold, P. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00791-8 · Cited by 260
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
Keller, J., Flores, B., Gomez, R. G., Solvason, H. B., Kenna, H., Williams, G. H., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.014 · Cited by 217
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208
Do antidepressants regulate how cortisol affects the brain?
Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.009 · Cited by 194
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
In vivo antioxidant status: A putative target of antidepressant action
Zafir, A., Ara, A., & Banu, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.010 · Cited by 183
Neuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Pariante, C. M., Makoff, A., Lovestone, S., Feroli, S., Heyden, A., Miller, A. H., & Kerwin, R. W. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704368 · Cited by 159
“For example, in animal studies, GR upregulation in the brain is induced by tricyclics (Eiring & Sulser, 1997; Reul et al., 1993; Rossby et al., 1995; Seckl & Fink, 1992) but not by SSRIs (Seckl & Fink, 1992).”
BackgroundSteroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine
Pariante, C. M., Pearce, B. D., Pisell, T. L., Owens, M. J., & Miller, A. H. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.571 · Cited by 156
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00008 · Cited by 152
Self-citationOtte, C., Hinkelmann, K., Moritz, S., Yassouridis, A., Jahn, H., Wiedemann, K., & Kellner, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.006 · Cited by 129
“Finally, animal studies demonstrated that antidepressants upregulate central MR (Brady et al., 1991; Seckl and Fink, 1992; Reul et al., 1993; Barden et al., 1995; Yau et al., 1995; Yau et al., 2002).”
BackgroundStout, S. C., Owens, M. J., & Nemeroff, C. B. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1085 · Cited by 117
“Antidepressant administration has been shown to increase the expression of type I and II glucocorticoid receptors in the hippocampus (Brady et al., 1991; Seckl and Fink, 1992; Reul et al., 1993); it is not known whether glucocorticoid receptor expression in the PVN is modified by antidepressant administration.”
BackgroundChandramohan, Y., Droste, S. K., & Reul, J. M. H. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04396.x · Cited by 117
“…after novelty stress occurred throughout the complete rostrocaudal axis of the hippocampus, which corresponds with the fact that exposure to a novel environment elicits behavioural, autonomic (Nijsen et al. 1998; van den Buuse et al. 2001) and neuroendocrine changes (Reul et al. 1993, 2000).”
BackgroundSelf-citationXing, G.-Q., Russell, S., Webster, M. J., & Post, R. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703004000 · Cited by 91
van Praag, H. M. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02923-x · Cited by 87
Otto, M. W., McHugh, R. K., & Kantak, K. M. (2010) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2010.01198.x · Cited by 87
Pariante, C. M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., & Kerwin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300195 · Cited by 70
Bauer, M. E., Papadopoulos, A., Poon, L., Perks, P., Lightman, S. L., Checkley, S., & Shanks, N. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00243-3 · Cited by 62
Suzuki, E., Shintani, F., Kanba, S., Asai, M., & Nakaki, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12985-2 · Cited by 55
Lechner, S. M., & Valentino, R. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)00900-7 · Cited by 51
Yau, J. L. W., Noble, J., Thomas, S., Kerwin, R., Morgan, P. E., Lightman, S., Seckl, J. R., & Pariante, C. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301389 · Cited by 46
Horstmann, S., Dose, T., Lucae, S., Kloiber, S., Menke, A., Hennings, J., Spieler, D., Uhr, M., Holsboer, F., & Ising, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.004 · Cited by 44
“GR sensitivity seems to be the prerequisite for a well-tuned hypothalamic CRH output finally leading to normalization of the HPA axis (Reul et al., 1993, 1994; Holsboer and Barden, 1996; Holsboer, 2000; Raison and Miller, 2003).”
BackgroundSelf-citationYau, J. L. W., Noble, J., Hibberd, C., & Seckl, J. R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01890-0 · Cited by 43
Aubry, J.-M. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.09.003 · Cited by 40
Heiske, A., Jesberg, J., Krieg, J.-C., & Vedder, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300056 · Cited by 35
Cognitive correlates of hypothalamic–pituitary–adrenal axis in major depression
Schlosser, N., Wolf, O. T., & Wingenfeld, K. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.79 · Cited by 33
Pariante, C. M., Alhaj, H. A., Arulnathan, V. E., Gallagher, P., Hanson, A., Massey, E., & McAllister-Williams, R. H. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.011 · Cited by 33
“Moreover, antidepressant treatment in rodents also induces GR down-regulation within the first few days of treatment (Reul et al., 1993; Yau et al., 2001), before the up-regulation occurs.”
BackgroundCRHR1 Antagonists as Novel Treatment Strategies
Holsboer, F. (2001) · CNS Spectrums · doi:10.1017/s1092852900002133 · Cited by 30
Self-citationTricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01491-0 · Cited by 17
Metadata
- Authors
- Reul, J. M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1993-07-01
- Volume
- 133
- Issue
- 1
- Pages
- 312-320
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2005231219
- Cited by
- 345
- References
- 40
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.